Loading clinical trials...
Loading clinical trials...
This is a follow-up study to evaluate the long term outcome of babies treated in the FIREFLEYE study.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Bayer
Collaborators
NCT07093255 · Retinopathy of Prematurity (ROP)
NCT06694103 · Retinopathy of Prematurity (ROP)
NCT07123948 · Retinopathy of Prematurity (ROP), Bronchopulmonary Dysplasia (BPD), and more
NCT07112430 · Neonatal Pain, Retinopathy of Prematurity (ROP), and more
NCT06775353 · Retinopathy of Prematurity (ROP)
Hospital Público Descentralizado "Dr. Guillermo Rawson"
San Juan
AZ Sint Jan Brugge - Ophthalmology
Bruges
Hospital das Clínicas de Botucatu - UNESP Botucatu
Botucatu, São Paulo
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions